Click for best price
Drugs for VancomycinResistant Enterococcus Faecium Market Size, Share 2022
This report contains market size and forecasts of Drugs for Vancomycin-Resistant Enterococcus Faecium in Global, including the following market information:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Daptomycin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Vancomycin-Resistant Enterococcus Faecium include Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma and MGB Biopharma Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Vancomycin-Resistant Enterococcus Faecium companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Type, 2021 (%)
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix
| Report Attributes |
Report Details |
| Report Title |
Drugs for Vancomycin-Resistant Enterococcus Faecium Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Overall Market Size
2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size: 2021 VS 2028
2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market
3.2 Top Global Drugs for Vancomycin-Resistant Enterococcus Faecium Companies Ranked by Revenue
3.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Markets, 2021 & 2028
4.1.2 Daptomycin
4.1.3 Linezolid
4.1.4 Quinupristin/dalfopristin
4.1.5 Ampicillin
4.1.6 Chloramphenicol
4.1.7 Others
4.2 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
4.2.1 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2022
4.2.2 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2023-2028
4.2.3 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
5.2.1 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2022
5.2.2 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2023-2028
5.2.3 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
6.2.1 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2022
6.2.2 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2023-2028
6.2.3 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028
6.3.2 US Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.3.3 Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.3.4 Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028
6.4.2 Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.3 France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.4 U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.5 Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.6 Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.7 Nordic Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.4.8 Benelux Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028
6.5.2 China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.5.3 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.5.4 South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.5.5 Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.5.6 India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028
6.6.2 Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.6.3 Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028
6.7.2 Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.7.3 Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
6.7.5 UAE Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2017-2028
7 Players Profiles
7.1 Alchemia Limited
7.1.1 Alchemia Limited Corporate Summary
7.1.2 Alchemia Limited Business Overview
7.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.1.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.1.5 Alchemia Limited Key News
7.2 Alvogen
7.2.1 Alvogen Corporate Summary
7.2.2 Alvogen Business Overview
7.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.2.4 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.2.5 Alvogen Key News
7.3 Aphios Corporation
7.3.1 Aphios Corporation Corporate Summary
7.3.2 Aphios Corporation Business Overview
7.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.3.4 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.3.5 Aphios Corporation Key News
7.4 Cellceutix Corporation
7.4.1 Cellceutix Corporation Corporate Summary
7.4.2 Cellceutix Corporation Business Overview
7.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.4.4 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.4.5 Cellceutix Corporation Key News
7.5 Enanta Pharmaceuticals
7.5.1 Enanta Pharmaceuticals Corporate Summary
7.5.2 Enanta Pharmaceuticals Business Overview
7.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.5.4 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.5.5 Enanta Pharmaceuticals Key News
7.6 Helix BioMedix
7.6.1 Helix BioMedix Corporate Summary
7.6.2 Helix BioMedix Business Overview
7.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.6.4 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.6.5 Helix BioMedix Key News
7.7 LegoChem Biosciences
7.7.1 LegoChem Biosciences Corporate Summary
7.7.2 LegoChem Biosciences Business Overview
7.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.7.4 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.7.5 LegoChem Biosciences Key News
7.8 Lytix Biopharma
7.8.1 Lytix Biopharma Corporate Summary
7.8.2 Lytix Biopharma Business Overview
7.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.8.4 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.8.5 Lytix Biopharma Key News
7.9 MGB Biopharma Limited
7.9.1 MGB Biopharma Limited Corporate Summary
7.9.2 MGB Biopharma Limited Business Overview
7.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.9.4 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.9.5 MGB Biopharma Limited Key News
7.10 Microbiotix
7.10.1 Microbiotix Corporate Summary
7.10.2 Microbiotix Business Overview
7.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.10.4 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2017-2022)
7.10.5 Microbiotix Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Opportunities & Trends in Global Market
Table 2. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Drivers in Global Market
Table 3. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Restraints in Global Market
Table 4. Key Players of Drugs for Vancomycin-Resistant Enterococcus Faecium in Global Market
Table 5. Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
Table 9. List of Global Tier 1 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2023-2028
Table 30. Alchemia Limited Corporate Summary
Table 31. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 32. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 33. Alvogen Corporate Summary
Table 34. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 35. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 36. Aphios Corporation Corporate Summary
Table 37. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 38. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 39. Cellceutix Corporation Corporate Summary
Table 40. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 41. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 42. Enanta Pharmaceuticals Corporate Summary
Table 43. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 44. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 45. Helix BioMedix Corporate Summary
Table 46. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 47. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 48. LegoChem Biosciences Corporate Summary
Table 49. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 50. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 51. Lytix Biopharma Corporate Summary
Table 52. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 53. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 54. MGB Biopharma Limited Corporate Summary
Table 55. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 56. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
Table 57. Microbiotix Corporate Summary
Table 58. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 59. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Type in 2021
Figure 2. Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Application in 2021
Figure 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2021
Figure 8. By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 12. US Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 16. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 24. China Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2017-2028
Figure 37. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
